231 reports of this reaction
2.7% of all DEXTROAMPHETAMINE SULFATE reports
#5 most reported adverse reaction
HEADACHE is the #5 most commonly reported adverse reaction for DEXTROAMPHETAMINE SULFATE, manufactured by Amneal Pharmaceuticals LLC. There are 231 FDA adverse event reports linking DEXTROAMPHETAMINE SULFATE to HEADACHE. This represents approximately 2.7% of all 8,480 adverse event reports for this drug.
Patients taking DEXTROAMPHETAMINE SULFATE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for DEXTROAMPHETAMINE SULFATE, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for DEXTROAMPHETAMINE SULFATE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 231 FDA reports for DEXTROAMPHETAMINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.7% of all adverse event reports for DEXTROAMPHETAMINE SULFATE, making it a notable side effect.
If you experience headache while taking DEXTROAMPHETAMINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.